Skip to main content
. 2021 Apr 25;23(10):1612–1676. doi: 10.1093/europace/euab065

Table 1.

Selected indications and contraindications for NOAC therapy in AF patients

graphic file with name euab065ilf1.jpg

Hatched, limited data; See text for details.

AF, atrial fibrillation; NOAC, non-vitamin K antagonist oral anticoagulant; RCT, randomized clinical trial; VKA, vitamin K antagonist.